A recently published study suggests medical marijuana may not be as effective as the narrative has suggested. Further, it may carry risk for addiction.
In the field of substance abuse, three connected factors are setting the stage for serious harm on America’s roads.
One of the most significant risks of using drugs is the possibility that an addict will unknowingly use a completely different drug from what they were expecting. This risk has been particularly evident with the recent surge in fatal fentanyl overdoses.
In recent years, there have been growing reports of fentanyl being laced into batches of marijuana, posing a severe risk to people who think they are using “just marijuana.”
People who use cannabis sometimes say that they feel okay to drive after an hour or two has passed. But are they really okay to drive? A new study shows they are not.
A common view shared by many people who consume alcohol is that limited, conservative alcohol consumption poses zero risks to one’s physical health. However, a new study indicates that even just one alcoholic beverage per day can reduce brain size over time.
In the now two-decade-long opioid epidemic in the U.S., pharmaceutical opioid manufacturers, pharmacies, and doctors have all come under fire for the role they played in the surge of opioid addiction and death. One group, previously unnoticed and only just now coming under investigation, bears mentioning. As reports have shown, pharmaceutical distributors had just as critical a role in the opioid epidemic as other bad actors.
One of the findings in the CDC’s 2020 Cause of Death report was that overdose deaths caused by fentanyl were the leading cause of death for adults ages 18 to 45. At first, this key fact went almost unnoticed. Only now is this critical issue getting the attention it deserves.
Headline after headline has broken with the news that Scotland is in the midst of the worst drug problem in Europe with the highest rate of drug overdose deaths in the region. And while this public health crisis is certainly newsworthy, some key details to it are not being fully considered.
A recent Massachusetts study sought to determine which demographics have been hit hardest by the opioid crisis. As it turns out, mainly working-class, blue-collar residents in construction, agriculture, forestry, fishing, hunting, and industrial jobs have been affected the most. But does this data also reflect a national trend?